This message was sent to ##Email##
|
|
|
|
|
AST
We are pleased to offer a complimentary live stream of select sessions during the 2020 Cutting Edge of Transplantation (CEoT) meeting!
The live stream will be available on March 5 - 7, 2020. Check out our website for more information.
Access this meeting from anywhere and join the conversation on social media by using #CEoT2020
AST
The recent outbreak of COVID-19 has led to questions among transplant programs, Organ Procurement Organizations (OPOs), and patients. Please visit the OPTN website for more information.
The AST's Infectious Disease Community of Practice (IDCOP) developed frequently asked questions sheet to relay information on the current state of 2019-nCoV knowledge after receiving queries from transplant colleagues.
AST
Visit the AST Member Spotlight page to read about Lara Danziger-Isakov's current projects.
Interested in being featured in the AST Member Spotlight? Please contact rpaulin@myast.org for more information.
READ MORE
AST
The Travel for Techniques in Transplantation Research (T3R) Program supports the travel of a scientist to the laboratory of another scientist to acquire a new technique. This program fulfills a goal of the AST Research Network to facilitate bringing novel, cutting edge techniques to transplant biology research labs and clinical scientists.
READ MORE
AST
The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020, also known as the Immuno Bill, was just introduced in the Senate. This legislation would extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients, which is currently limited to just 36 months. Please take a moment to contact your Senators about this important legislation (and if you haven’t already, please also reach out to your House representative to do the same!)
Contact Congress Today
 |
|
Promoted by
Veloxis Pharmaceuticals
Now you can see the different ways that different formulations are released and absorbed in the gastrointestinal system. You’ll also have the opportunity to explore comparative pharmacokinetic results in rapid metabolizers, efficacy data over 2 years, and safety information.
Watch Video
|
|
AST
The Transplantation Society in collaboration with the American Society of Transplantation (AST), acknowledges the contribution of basic science to the field of transplantation by offering Mentee-Mentor awards. The International Transplantation Science Mentee-Mentor Awards aim is to encourage young investigators to submit their research to TTS 2020 and help cover expenses to attend the Congress in Seoul. For more information about the awards and eligibility, click here.
AST
The Transplant Nephrology Core Curriculum (TNCC) is an online program jointly provided by the American Society of Nephrology and the American Society of Transplantation. The TNCC focuses on key information needed to prepare for the American Board of Internal Medicine Nephrology Board Certification and Maintenance of Certification examinations.
READ MORE
Advertisement
Veloxis Pharmaceuticals
Immunosuppressive medications can be a financial burden for kidney transplant patients, potentially costing as much as $10,000 to $14,000 a year. These expenses can have a negative impact on patients’ lives and may play a role in medication nonadherence, which is associated with transplant failure. Learn more about support that is available with a free 30-day trial to allow your patients to start immediately at no cost. And, for patients who are eligible with commercial insurance coverage, a $0 co-pay card offers significant savings.
Find out more
|
AST
Transplant professionals have increasing demands on their time. Finding time in one’s day to attend conferences or to read journals is challenging. Transplant in 10 is intended to provide transplant professionals with short, easily accessible videos on key and updated topics in 10 minutes.
READ MORE
|
|
| | UPCOMING EDUCATION EVENTS |
AST
March 12, 2020 | 2 pm ET | Online Activity
For more information, click here
AST
March 24, 2020 | 2 pm ET | Online Activity
For more information, click here
|
TruGraf® - The 1st and only non-invasive test to rule out “silent" subclinical rejection in stable kidney transplant recipients
The only test to be reimbursed as an alternative to surveillance biopsies
Developed by Clinicians for Clinicians
Learn More
|
|
|
|
|
Reach Your Prospects Every Week
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
Journal of the American Medical Association
In this cohort study of 166 patients with stage 5 chronic kidney disease and 87 patients with hypertension only to assess change to cardiovascular functional reserve after improving the uremic milieu through a kidney transplant using state-of-the-art cardiopulmonary exercise testing, improved cardiovascular functional reserve was seen one year after kidney transplant in the absence of significant alterations in left ventricular morphologic findings.
READ MORE
American Asssociatoin for the Study of Liver Diseases
The aim of this study was to analyze long‐term patient and graft survival after liver transplantation for autoimmune hepatitis (AIH‐LT) from the prospective multicenter European Liver Transplant Registry. After AIH‐LT, patient survival was 79.4%, 70.8% and 60.3% and graft survival 73.2%, 63.4% and 50.9% after 5, 10 and 15 years respectively of follow‐up.
READ MORE
|
|
American Journal of Transplantation via Wiley Online Library
Uncontrolled donation after cardiac death (uDCD) has the potential to ameliorate the shortage of suitable lungs for transplant. To date, no lung transplant data from these donors are available from North America. We describe the successful use of these donors using a simple method of in situ lung inflation so that the organ can be protected from warm ischemic injury. Forty‐four potential donors were approached, and family consent was obtained in 30 cases. Of these, the lung transplant team evaluated 16 uDCDs on site, and 14 were considered for transplant pending ex vivo lung perfusion assessment.
READ MORE
Pediactric Transplantation via Wiley Online Library
This study aimed to investigate the incidence of PTLD in pediatric liver transplant recipients and the risk factors for the development of PTLD. We also determined clinically useful quantitative EBV PCR parameters for aiding in the diagnosis of EBV‐associated PTLD in the pediatric liver transplant recipients at our institute. We reviewed children < 18 years old who had undergone liver transplantations and quantitative analysis of whole blood EBV load at our institute from January 2006 to March 2015.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
